Novel active substance launches
Total number of novel active substances launched.
Unit Count Industry Pharmaceuticals
The chart
Over time
Global over time, then the latest value of every region, ranked. Forecasts are dashed with hollow markers; the underlying values are one click away under the chart.
Novel active substance launches
Global, 2004–2023 to 2025
Novel active substance launches by region
Latest value per region, 2025
View the underlying data
| Category | Source | Type | Value |
|---|---|---|---|
| Global | IQVIA | Actual | 79 |
| United States | IQVIA | Actual | 53 |
| Germany | VFA | Actual | 37 |
Every record
All records
7 records · 3 regions · 2004–2025
| Period | Value | Source | Type |
|---|---|---|---|
| Global 4 records | |||
| 2025 | 79 | IQVIA · 31 Dec 2025 | actual |
| 2025 | 79 | IQVIA · 31 Dec 2025 | actual |
| 2025 | 79 | IQVIA · 31 Dec 2025 | actual |
| 2004–2023 | 942 | IFPMA · 31 Dec 2023 | actual |
| United States 2 records | |||
| 2025 | 53 | IQVIA · 31 Dec 2025 | actual |
| 2025 | 53 | IQVIA · 31 Dec 2025 | actual |
| Germany 1 record | |||
| 2025 | 37 | VFA · 31 Dec 2025 | actual |
Primary documents
Sources
5 documents. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| Enabling innovation: The R&D ecosystem for medicines and vaccines | IFPMA | — | 1 |
| Neue Medikamente in Deutschland: Innovationsbilanz 2025 | VFA | — | 1 |
| Global R&D Trends 2026 | IQVIA | — | 2 |
| Global R&D Trends 2026 | IQVIA | — | 2 |
| IQVIA Institute’s Global R&D Trends 2026 Report Finds Credible Signal on AI-Enabled Programs | IQVIA | — | 1 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Novel active substance launches. Retrieved from https://statorigin.org/indicators/novel-active-substance-launches